StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300437.SZ$12.39-2.13%
Fair $12.39+0.0%

300437.SZ

Henan Qingshuiyuan Technology CO.,Ltd

Basic Materials / Specialty ChemicalsShenzhen

$12.39

-0.27 (-2.13%)

Fairly Valued+0.0%Fair Value $12.39Fund rank 29/100 · Data gapFallback financials|
SA 22/D
F-Score: 6/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $93.0M · quality 58.7/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 44/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

22/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. Revenue has declined for 3 consecutive years ROE is -2.9%, below the 5% threshold
Thesis & Journal · 300437.SZLocal privado en este navegador · Henan Qingshuiyuan Technology CO.,Ltd
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.0B

P/E

N/A

•

EV/EBITDA

51.9x

↑

ROE

-2.9%

↓

Gross Margin

10.7%

↓

Debt/Equity

0.30

↑
52-Week Range$12
$8$26

TradingView lightweight chart

300437.SZ price, volumen y niveles de valoración

Último $12.39Periodo +128.8%
Fair value: $12.39

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-21.6%

FCF CAGR

+13.7%

FCF margin

10.7%

FCF / Net income

-2.29x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $868.8M · net income $-40.6M · FCF $93.0M

2022-FY → 2025-FY

Gross margin

10.7%-6.0% pts

Operating margin

0.2%-8.7% pts

Net margin

-4.7%-2.3% pts

FCF margin

10.7%+7.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$868.8M$868.8M$1.09B$1.13B$1.80B
Net Income$-40.6M$-40.6M$-58.6M$-55.8M$-42.5M
EBITDA$63.1M$63.1M$47.0M$54.4M$78.0M
EPS-0.16-0.16-0.23-0.22-0.16
Gross Margin10.7%10.7%10.6%11.0%16.7%
Operating Margin0.2%0.2%1.0%0.8%8.9%
Net Margin-4.7%-4.7%-5.4%-4.9%-2.4%
Balance Sheet
Debt/Equity0.300.300.340.370.46
Current Ratio1.531.53———
Cash Flow
Free Cash Flow$93.0M$93.0M$93.3M$41.1M$63.3M
Returns
ROE-2.9%-2.9%-4.1%-3.7%-2.8%
Valuation
EV/EBITDA51.8551.8547.7062.6362.06
P/B2.332.331.522.183.03
Growth & Yield
Revenue Growth-20.4%-20.4%-3.8%-37.1%—
EPS Growth31.7%31.7%-5.7%-31.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +50.0%

Total return

+50.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.23 → -0.16

Residual

+50.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+50.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.